Skip to main content

Health In Tech, Inc.

HIT
Exchange
Nasdaq
Industry
Insurance Agents, Brokers & Service
SEC CIK
0002019505

In the last 90 days, Health In Tech, Inc. insiders filed 0 open-market purchases and 5 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $4.72M in total; no superinvestor holds it.

Key figures

Market capNo recent share count in SEC filings
–
Insider buysOpen market, last 90 days
0
Insider sellsLast 90 days, $40.7K in total
5
13F holdersQ2 2026, +6 vs. previous quarter
21
13F valueReported value at the end of Q2 2026
$4.72M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$33.3M
+71.0% year over year
Net income, FY2025
$1.28M
+90.7% year over year
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q2 FY2026
$8.06M
−13.5% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
602.4K
Shares sold short
Change
+179.2K
+42.3% vs. previous
Days to cover
10.34
At average daily volume

Superinvestors holding HIT, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding HIT at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Health In Tech, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 5, 2026 (view filing)4:30 PM ETNov 32 daysHasan Zain SyedChief Growth OfficerSSaleClass A Common Stock−1.67K$0.55−$916.85−1.0%172.0K after10b5-1
Oct 19, 2026 (view filing)7:04 PM ETOct 163 daysHasan Zain SyedChief Growth OfficerSSaleClass A Common Stock−3.33K$0.62−$2.07K−1.9%173.7K after10b5-1
Sep 15, 2026 (view filing)4:05 PM ETSep 141 dayHayes TimothyDirectorSSaleClass A Common Stock−12.0K$0.893−$10.7K−9.9%108.8K after
Sep 14, 2026 (view filing)8:55 AM ETSep 113 daysHasan Zain SyedChief Growth OfficerSSaleClass A Common Stock−11.7K$0.92−$10.7K−5.8%188.5K after10b5-1
Sep 11, 2026 (view filing)9:14 PM ETSep 9-112 daysHayes TimothyDirectorSSaleClass A Common Stock−17.7K$0.9165−$16.2K−12.8%120.8K after2 lots

Top 10 13F holders, Q2 2026

See all 21 holders

The largest institutional positions in Health In Tech, Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding HIT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Whetstone Capital Advisors, LLC1,509,766$1.52M0.40%+1,509,766New
Mink Brook Asset Management LLC1,133,369$1.14M0.51%+326,908+40.5%Added
Vanguard Capital Management LLC568,475$574.2K0.00%+3,000+0.5%Added
Heights Capital Management, Inc350,268$353.8K0.08%−23,030−6.2%Reduced
BlackRock, Inc.349,595$353.1K0.00%+64,940+22.8%Added
Geode Capital Management, LLC220,650$222.9K0.00%+37,325+20.4%Added
Citadel Advisors LLC176,911$178.7K0.00%+140,279+382.9%Added
Vanguard Fiduciary Trust Co130,482$131.8K0.00%+55,914+75.0%Added
State Street Corp62,900$63.5K0.00%00.0%Unchanged
Northern Trust Corp57,659$58.2K0.00%+21,509+59.5%Added

Holders of 5% or more of HIT

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Health In Tech, Inc..

Largest holders of HIT from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Johnson Tim Donald13G60.40%32.2M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC
Qian LinLin13G24.40%11.4M sharesNewFeb 14, 20251 filingFeb 14, 2025SEC
Lytton Laurence W13G6.20%3.32M sharesNewSep 29, 20261 filingSep 29, 2026SEC